Description
This diagram was developed along with a 3D medical animation that explains the mechanism-of-action (MoA) of a latest cancer therapy treatment called Neuvax — the immunodominant nine amino acid peptide derived from the extracellular domain of the HER2 protein. This medical illustration is part of a corporate and investor presentation.
Client:
Galena Biopharma
Deliverables:
Corporate, Investor Presentations